UK markets closed

RTW Biotech Opportunities Ord (RTW.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
1.3150-0.0050 (-0.38%)
At close: 04:09PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
-146,955
86,296
-36,510
-60,920
162,774
Operating expenses
Selling general and administrative
3,109
3,104
2,927
3,425
2,121
Total operating expenses
3,111
3,104
2,927
3,425
2,121
Interest expense
248.432
1,560
779.988
215.606
73.545
Income before tax
-150,066
83,192
-39,437
-64,345
160,654
Income from continuing operations
-150,066
83,192
-39,437
-64,345
160,654
Net income
-150,066
83,192
-39,437
-64,345
160,654
Net income available to common shareholders
-150,066
83,192
-39,437
-64,345
160,654
Basic EPS
0.43
-
-0.17
-0.27
0.67
Diluted EPS
0.43
-
-0.17
-0.27
0.67
Basic average shares
235,125
-
231,981
238,314
239,781
Diluted average shares
235,125
-
231,981
238,314
239,781